Teun van Gelder

Research interests

Publications

• Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

  Therapeutic Drug Monitoring · 2021 · 10.1097/ftd.0000000000000871

• Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

  Therapeutic Drug Monitoring · 2019 · https://doi.org/10.1097/ftd.0000000000000640

• Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients

  Transplantation · 2017 · https://doi.org/10.1097/tp.0000000000001651

• A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype‐Based With Body‐Weight‐Based Tacrolimus Dosing After Living Donor Kidney Transplantation

  American Journal of Transplantation · 2015 · 10.1111/ajt.13691

• Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management

  Transplantation Reviews · 2015 · 10.1016/j.trre.2015.01.002

• Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective

  The Lancet Oncology · 2014 · 10.1016/s1470-2045(13)70579-5

• Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials

  American Journal of Transplantation · 2013 · 10.1111/ajt.12191

• Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

  British Journal of Cancer · 2013 · 10.1038/bjc.2013.48

• The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation

  Clinical Pharmacokinetics · 2013 · 10.1007/s40262-013-0120-3

• CYP3A4*22: Promising Newly IdentifiedCYP3A4Variant Allele for Personalizing Pharmacotherapy

  Pharmacogenomics · 2012 · 10.2217/pgs.12.187

• A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients

  Clinical Chemistry · 2011 · 10.1373/clinchem.2011.165613

• High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation

  Nephrology Dialysis Transplantation · 2010 · 10.1093/ndt/gfq096

• Consensus Report on Therapeutic Drug Monitoring of Mycophenolic Acid in Solid Organ Transplantation

  Clinical Journal of the American Society of Nephrology · 2010 · https://doi.org/10.2215/cjn.07111009

• Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain‐Barré syndrome

  Annals of Neurology · 2009 · 10.1002/ana.21737

• Turning Off Frequently Overridden Drug Alerts: Limited Opportunities for Doing It Safely

  Journal of the American Medical Informatics Association · 2008 · 10.1197/jamia.m2311

• Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial

  Transplantation · 2008 · 10.1097/tp.0b013e318186f98a

• Explaining Variability in Mycophenolic Acid Exposure to Optimize Mycophenolate Mofetil Dosing

  Journal of the American Society of Nephrology · 2006 · 10.1681/asn.2005101070

• Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation

  Therapeutic Drug Monitoring · 2006 · https://doi.org/10.1097/01.ftd.0000199358.80013.bd

• Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance-Associated Protein 2

  American Journal of Transplantation · 2005 · 10.1046/j.1600-6143.2005.00779.x

• PROTEINURIA AFTER RENAL TRANSPLANTATION AFFECTS NOT ONLY GRAFT SURVIVAL BUT ALSO PATIENT SURVIVAL

  Transplantation · 2001 · 10.1097/00007890-200108150-00014

• Comparison of the Effects of Tacrolimus and Cyclosporine on the Pharmacokinetics of Mycophenolic Acid

  Therapeutic Drug Monitoring · 2001 · https://doi.org/10.1097/00007691-200104000-00005

• Current Issues in Therapeutic Drug Monitoring of Mycophenolic Acid: Report of a Roundtable Discussion

  Therapeutic Drug Monitoring · 2001 · 10.1097/00007691-200108000-00001

• A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1

  Transplantation · 1999 · https://doi.org/10.1097/00007890-199907270-00018

• EFFECT OF CYCLOSPORINE ON MYCOPHENOLIC ACID TROUGH LEVELS IN KIDNEY TRANSPLANT RECIPIENTS1

  Transplantation · 1999 · 10.1097/00007890-199911270-00028

• The Effect of Tolerance to Noninherited Maternal HLA Antigens on the Survival of Renal Transplants from Sibling Donors

  New England Journal of Medicine · 1998 · 10.1056/nejm199812033392302

Current projects

No projects listed.